Skip to main content
SpringerLink
Log in

Pro-tumorigenic and Anti-tumorigenic Roles of Pro-inflammatory Cytokines in Cancer

  • Living reference work entry
  • First Online:
Handbook of Cancer and Immunology

Abstract

Interaction between inflammation and tumor microenvironment (TME) is known as one of the main causes of cancer development. TME is an intricate network composed of tumor and immune cells, cytokines, enzymes, and other related factors. Pro-inflammatory cytokines, mostly IL-1 family, IL-6, and TNF-α, are key factors in creating chronic inflammation in the tumor context. Based on reported evidence, these cytokines indicate either pro-tumorigenic or anti-tumorigenic functions dependent on cancer type, TME, and other related factors. As the pro-tumorigenic function, the pro-inflammatory cytokines alongside supportive cells and factors lead to hyperinflammation and tumor promotion by affecting different mechanisms, including angiogenesis, proliferation, immunosuppression, extracellular matrix remodeling, invasiveness, and metastasis. Regarding the importance of tumor immunopathogenesis, attracting attention to inflammation and the abovementioned cytokines is critically required. Hence, this study aimed to discuss the role of the pro-inflammatory cytokine in cancers comprehensively, which would help open a window toward depth recognition of cancer pathogenesis and increase the efforts to improve and develop practical cancer therapeutic approaches.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution

Institutional subscriptions

References

  • Allen IC, TeKippe EM, Woodford R-MT, Uronis JM, Holl EK, Rogers AB et al (2010) The NLRP3 inflammasome functions as a negative regulator of tumorigenesis during colitis-associated cancer. J Exp Med 207(5):1045–1056

    Article  CAS  Google Scholar 

  • Ando M, Uehara I, Kogure K, Asano Y, Nakajima W, Abe Y et al (2010) Interleukin 6 enhances glycolysis through expression of the glycolytic enzymes hexokinase 2 and 6-phosphofructo-2-kinase/fructose-2,6-bisphosphatase-3. J Nippon Med School 77(2):97–105

    Article  CAS  Google Scholar 

  • Apte RN, Voronov E (2017) Immunotherapeutic approaches of IL-1 neutralization in the tumor microenvironment. J Leukoc Biol 102(2):293–306

    Article  CAS  Google Scholar 

  • Arnott CH, Scott KA, Moore RJ, Hewer A, Phillips DH, Parker P et al (2002) Tumour necrosis factor-α mediates tumour promotion via a PKCα-and AP-1-dependent pathway. Oncogene 21(31):4728–4738

    Article  CAS  Google Scholar 

  • Baker KJ, Houston A, Brint E (2019) IL-1 family members in cancer; two sides to every story. Front Immunol 10:1197

    Article  CAS  Google Scholar 

  • Balkwill FR, Mantovani A (2012) Cancer-related inflammation: common themes and therapeutic opportunities. Semin Cancer Biol 22(1):33–40

    Article  CAS  Google Scholar 

  • Bharti R, Dey G, Mandal M (2016) Cancer development, chemoresistance, epithelial to mesenchymal transition and stem cells: a snapshot of IL-6 mediated involvement. Cancer Lett 375(1):51–61

    Article  CAS  Google Scholar 

  • Bhattacharyya S, Mandal D, Sen GS, Pal S, Banerjee S, Lahiry L et al (2007) Tumor-induced oxidative stress perturbs nuclear factor-kappaB activity-augmenting tumor necrosis factor-alpha-mediated T-cell death: protection by curcumin. Cancer Res 67(1):362–370

    Article  CAS  Google Scholar 

  • Biswas SK (2015) Metabolic reprogramming of immune cells in cancer progression. Immunity 43(3):435–449

    Article  CAS  Google Scholar 

  • Briukhovetska D, Dörr J, Endres S, Libby P, Dinarello CA, Kobold S (2021) Interleukins in cancer: from biology to therapy. Nat Rev Cancer 21(8):481–499

    Article  CAS  Google Scholar 

  • Browning L, Patel MR, Horvath EB, Tawara K, Jorcyk CL (2018) IL-6 and ovarian cancer: inflammatory cytokines in promotion of metastasis. Cancer Manag Res 10:6685

    Article  CAS  Google Scholar 

  • Celik A, Bakar-Ates F (2021) The confounding effect of interleukin-6 on apoptosis of MCF-7 cells through down-regulation of MMP-2/−9 mRNA expression. Turk J Biochem 46(5):549–555

    Article  Google Scholar 

  • Chen Y, Zhang F, Tsai Y, Yang X, Yang L, Duan S et al (2015) IL-6 signaling promotes DNA repair and prevents apoptosis in CD133+ stem-like cells of lung cancer after radiation. Radiat Oncol 10(1):1–10

    Article  Google Scholar 

  • Chen Y, Wen H, Zhou C, Su Q, Lin Y, Xie Y et al (2019) TNF-α derived from M2 tumor-associated macrophages promotes epithelial-mesenchymal transition and cancer stemness through the Wnt/β-catenin pathway in SMMC-7721 hepatocellular carcinoma cells. Exp Cell Res 378(1):41–50

    Article  CAS  Google Scholar 

  • Chonov DC, Ignatova MMK, Ananiev JR, Gulubova MV (2019) IL-6 activities in the tumour microenvironment. Part 1. Open Access Maced J Med Sci 7(14):2391

    Article  Google Scholar 

  • Coca S, Perez-Piqueras J, Martinez D, Colmenarejo A, Saez MA, Vallejo C et al (1997) The prognostic significance of intratumoral natural killer cells in patients with colorectal carcinoma. Cancer 79(12):2320–2328

    Article  CAS  Google Scholar 

  • Comen E, Wojnarowicz P, Seshan VE, Shah R, Coker C, Norton L et al (2016) TNF is a key cytokine mediating neutrophil cytotoxic activity in breast cancer patients. NPJ Breast Cancer 2:16009

    Article  Google Scholar 

  • Dinarello CA (1996) Biologic basis for interleukin-1 in disease. Blood 87(6):2095–2147

    Article  CAS  Google Scholar 

  • Dinarello CA (2006) The paradox of pro-inflammatory cytokines in cancer. Cancer Metastasis Rev 25(3):307–313

    Article  CAS  Google Scholar 

  • Du Z, Lovly CM (2018) Mechanisms of receptor tyrosine kinase activation in cancer. Mol Cancer 17(1):58

    Article  Google Scholar 

  • Fajardo LF, Kwan HH, Kowalski J, Prionas SD, Allison AC (1992) Dual role of tumor necrosis factor-alpha in angiogenesis. Am J Pathol 140(3):539–544

    CAS  Google Scholar 

  • Greenwel P, Tanaka S, Penkov D, Zhang W, Olive M, Moll J et al (2000) Tumor necrosis factor alpha inhibits type I collagen synthesis through repressive CCAAT/enhancer-binding proteins. Mol Cell Biol 20(3):912–918

    Article  CAS  Google Scholar 

  • Grivennikov SI (2013) Inflammation and colorectal cancer: colitis-associated neoplasia. Semin Immunopathol 35(2):229–244

    Article  CAS  Google Scholar 

  • Hirano S, Kataoka T (2013) Deoxynivalenol induces ectodomain shedding of TNF receptor 1 and thereby inhibits the TNF-α-induced NF-κB signaling pathway. Eur J Pharmacol 701(1–3):144–151

    Article  CAS  Google Scholar 

  • Holen I, Lefley DV, Francis SE, Rennicks S, Bradbury S, Coleman RE et al (2016) IL-1 drives breast cancer growth and bone metastasis in vivo. Oncotarget 7(46):75571

    Article  Google Scholar 

  • Huerta-Yepez S, Vega M, Garban H, Bonavida B (2006) Involvement of the TNF-alpha autocrine-paracrine loop, via NF-kappaB and YY1, in the regulation of tumor cell resistance to Fas-induced apoptosis. Clin Immunol (Orlando, Fla) 120(3):297–309

    Article  CAS  Google Scholar 

  • Jones SA, Scheller J, Rose-John S (2011) Therapeutic strategies for the clinical blockade of IL-6/gp130 signaling. J Clin Invest 121(9):3375–3383

    Article  CAS  Google Scholar 

  • Kang JS, Y. Bae S, H. Kim R, Kim YS, J. Kim D, Cho BJ et al (2009) Interleukin-18 increases metastasis and immune escape of stomach cancer via the downregulation of CD70 and maintenance of CD44. Carcinogenesis 30(12):1987–1996

    Article  CAS  Google Scholar 

  • Kaplanski G, Farnarier C, Kaplanski S, Porat R, Shapiro L, Bongrand P et al (1994) Interleukin-1 induces interleukin-8 secretion from endothelial cells by a juxtacrine mechanism. Blood 84:4242–4248

    Article  CAS  Google Scholar 

  • Kawada M, Ishizuka M, Takeuchi T (1999) Enhancement of antiproliferative effects of interleukin-1β and tumor necrosis factor-α on human prostate cancer LNCaP cells by coculture with normal fibroblasts through secreted interleukin-6. Jpn J Cancer Res 90(5):546–554

    Article  CAS  Google Scholar 

  • Kim K, Song H, Kim TS, Yoon D, Kim C, Bang S et al (2007) Interleukin-18 is a critical factor for vascular endothelial growth factor-enhanced migration in human gastric cancer cell lines. Oncogene 26(10):1468–1476

    Article  CAS  Google Scholar 

  • Kim J, Lee J, Oh JH, Chang HJ, Sohn DK, Shin A et al (2019) Circulating interleukin-6 level, dietary antioxidant capacity, and risk of colorectal cancer. Antioxidants 8(12):595

    Article  CAS  Google Scholar 

  • Kumari N, Dwarakanath B, Das A, Bhatt AN (2016) Role of interleukin-6 in cancer progression and therapeutic resistance. Tumor Biol 37(9):11553–11572

    Article  CAS  Google Scholar 

  • Laha D, Grant R, Mishra P, Nilubol N (2021) The role of tumor necrosis factor in manipulating the immunological response of tumor microenvironment. Front Immunol 12:656908

    Article  Google Scholar 

  • Lan T, Chen L, Wei X (2021) Inflammatory cytokines in cancer: comprehensive understanding and clinical progress in gene therapy. Cells 10(1):100

    Article  CAS  Google Scholar 

  • Laronha H, Caldeira J (2020) Structure and function of human matrix metalloproteinases. Cells 9(5):1076

    Article  CAS  Google Scholar 

  • Letterio JJ, Roberts AB (1998) Regulation of immune responses by TGF-beta. Annu Rev Immunol 16:137–161

    Article  CAS  Google Scholar 

  • Li L, Hong Z (2016) IL-1β/NF-kb signaling promotes colorectal cancer cell growth through miR-181a/PTEN axis. Arch Biochem Biophys 604:20–26

    Article  Google Scholar 

  • Li Y, Wang L, Pappan L, Galliher-Beckley A, Shi J (2012) IL-1β promotes stemness and invasiveness of colon cancer cells through Zeb1 activation. Mol Cancer 11(1):1–13

    Article  CAS  Google Scholar 

  • Lin Y, He Z, Ye J, Liu Z, She X, Gao X et al (2020) Progress in understanding the IL-6/STAT3 pathway in colorectal cancer. Onco Targets Ther 13:13023

    Article  CAS  Google Scholar 

  • Liu S, Lee JS, Jie C, Park MH, Iwakura Y, Patel Y et al (2018) HER2 overexpression triggers an IL1α proinflammatory circuit to drive tumorigenesis and promote chemotherapy resistance. Cancer Res 78(8):2040–2051

    Article  CAS  Google Scholar 

  • Luo JL, Maeda S, Hsu LC, Yagita H, Karin M (2004) Inhibition of NF-kappaB in cancer cells converts inflammation- induced tumor growth mediated by TNFalpha to TRAIL-mediated tumor regression. Cancer Cell 6(3):297–305

    Article  CAS  Google Scholar 

  • Mantovani A, Barajon I, Garlanda C (2018) IL-1 and IL-1 regulatory pathways in cancer progression and therapy. Immunol Rev 281(1):57–61

    Article  CAS  Google Scholar 

  • Mercogliano MF, Bruni S, Mauro F, Elizalde PV, Schillaci R (2021) Harnessing tumor necrosis factor alpha to achieve effective cancer immunotherapy. Cancers 13(3):564

    Article  CAS  Google Scholar 

  • Mikesh LM, Kumar M, Erdag G, Hogan KT, Molhoek KR, Mayo MW et al (2010) Evaluation of molecular markers of mesenchymal phenotype in melanoma. Melanoma Res 20(6):485–495

    Article  CAS  Google Scholar 

  • Mittal V (2018) Epithelial mesenchymal transition in tumor metastasis. Annu Rev Pathol 13:395–412

    Article  CAS  Google Scholar 

  • Nakamura K, Kassem S, Cleynen A, Chrétien M-L, Guillerey C, Putz EM et al (2018) Dysregulated IL-18 is a key driver of immunosuppression and a possible therapeutic target in the multiple myeloma microenvironment. Cancer Cell. 33(4):634–48.e5

    Article  CAS  Google Scholar 

  • Oh K, Lee O-Y, Park Y, Seo MW, Lee D-S (2016) IL-1β induces IL-6 production and increases invasiveness and estrogen-independent growth in a TG2-dependent manner in human breast cancer cells. BMC Cancer 16(1):1–11

    Article  CAS  Google Scholar 

  • Pileczki V, Braicu C, Gherman CD, Berindan-Neagoe I (2012) TNF-α gene knockout in triple negative breast cancer cell line induces apoptosis. Int J Mol Sci 14(1):411–420

    Article  Google Scholar 

  • Porta C, Rimoldi M, Raes G, Brys L, Ghezzi P, Di Liberto D et al (2009) Tolerance and M2 (alternative) macrophage polarization are related processes orchestrated by p50 nuclear factor kappaB. Proc Natl Acad Sci U S A 106(35):14978–14983

    Article  CAS  Google Scholar 

  • Pyonteck SM, Akkari L, Schuhmacher AJ, Bowman RL, Sevenich L, Quail DF et al (2013) CSF-1R inhibition alters macrophage polarization and blocks glioma progression. Nat Med 19(10):1264–1272

    Article  CAS  Google Scholar 

  • Radharani N, Yadav AS, Nimma R, Kumar T, Bulbule A, Chanukuppa V et al (2022) Tumor-associated macrophage derived IL-6 enriches cancer stem cell population and promotes breast tumor progression via Stat-3 pathway. Cancer Cell Int 22(1):1–19

    Article  Google Scholar 

  • Rider P, Carmi Y, Voronov E, Apte RN, editors (2013) Interleukin-1α. Seminars in immunology. Elsevier

    Google Scholar 

  • Sabio G, Davis RJ (2014) TNF and MAP kinase signalling pathways. Semin Immunol 26(3):237–245

    Article  CAS  Google Scholar 

  • Sade-Feldman M, Kanterman J, Ish-Shalom E, Elnekave M, Horwitz E, Baniyash M (2013) Tumor necrosis factor-α blocks differentiation and enhances suppressive activity of immature myeloid cells during chronic inflammation. Immunity 38(3):541–554

    Article  CAS  Google Scholar 

  • Sasi SP, Yan X, Enderling H, Park D, Gilbert HY, Curry C et al (2012) Breaking the ‘harmony’ of TNF-α signaling for cancer treatment. Oncogene 31(37):4117–4127

    Article  CAS  Google Scholar 

  • Sawai H, Funahashi H, Yamamoto M, Okada Y, Hayakawa T, Tanaka M et al (2003) Interleukin-1α enhances integrin α6β1 expression and metastatic capability of human pancreatic cancer. Oncology 65(2):167–173

    Article  CAS  Google Scholar 

  • Schweighofer B, Testori J, Sturtzel C, Sattler S, Mayer H, Wagner O et al (2009) The VEGF-induced transcriptional response comprises gene clusters at the crossroad of angiogenesis and inflammation. Thromb Haemost 102(09):544–554

    Article  CAS  Google Scholar 

  • Soria G, Ofri-Shahak M, Haas I, Yaal-Hahoshen N, Leider-Trejo L, Leibovich-Rivkin T et al (2011) Inflammatory mediators in breast cancer: coordinated expression of TNFα & IL-1β with CCL2 & CCL5 and effects on epithelial-to-mesenchymal transition. BMC Cancer 11:130

    Article  CAS  Google Scholar 

  • Sun R, Luo J, Li D, Shu Y, Luo C, Wang SS et al (2014) Neutrophils with protumor potential could efficiently suppress tumor growth after cytokine priming and in presence of normal NK cells. Oncotarget 5(24):12621–12634

    Article  Google Scholar 

  • Tang D, Tao D, Fang Y, Deng C, Xu Q, Zhou J (2017) TNF-alpha promotes invasion and metastasis via NF-kappa B pathway in oral squamous cell carcinoma. Med Sci Monit Basic Res 23:141–149

    Article  Google Scholar 

  • Taniguchi K, Karin M (2018) NF-κB, inflammation, immunity and cancer: coming of age. Nat Rev Immunol 18(5):309–324

    Article  CAS  Google Scholar 

  • Voronov E, Shouval DS, Krelin Y, Cagnano E, Benharroch D, Iwakura Y et al (2003) IL-1 is required for tumor invasiveness and angiogenesis. Proc Natl Acad Sci 100(5):2645–2650

    Article  CAS  Google Scholar 

  • Voronov E, Carmi Y, Apte RN (2014) The role IL-1 in tumor-mediated angiogenesis. Front Physiol 5:114

    Article  Google Scholar 

  • Wang H, Wang HS, Zhou BH, Li CL, Zhang F, Wang XF et al (2013) Epithelial-mesenchymal transition (EMT) induced by TNF-α requires AKT/GSK-3β-mediated stabilization of snail in colorectal cancer. PLoS One 8(2):e56664

    Article  CAS  Google Scholar 

  • Wang Y, Wang Y, Duan X, Wang Y, Zhang Z (2018) Interleukin-1 receptor-associated kinase 1 correlates with metastasis and invasion in endometrial carcinoma. J Cell Biochem 119(3):2545–2555

    Article  CAS  Google Scholar 

  • Weber A, Wasiliew P, Kracht M (2010) Interleukin-1β (IL-1β) processing pathway. Sci Signal 3(105):cm1–cm1

    Google Scholar 

  • Weichand B, Popp R, Dziumbla S, Mora J, Strack E, Elwakeel E et al (2017) S1PR1 on tumor-associated macrophages promotes lymphangiogenesis and metastasis via NLRP3/IL-1β. J Exp Med 214(9):2695–2713

    Article  CAS  Google Scholar 

  • Yamane K, Ihn H, Asano Y, Jinnin M, Tamaki K (2003) Antagonistic effects of TNF-alpha on TGF-beta signaling through down-regulation of TGF-beta receptor type II in human dermal fibroblasts. J Immunol (Baltimore, Md: 1950) 171(7):3855–3862

    Article  CAS  Google Scholar 

  • Yan B, Wang H, Rabbani ZN, Zhao Y, Li W, Yuan Y et al (2006) Tumor necrosis factor-alpha is a potent endogenous mutagen that promotes cellular transformation. Cancer Res 66(24):11565–11570

    Article  CAS  Google Scholar 

  • Yang H, Bocchetta M, Kroczynska B, Elmishad AG, Chen Y, Liu Z et al (2006) TNF-α inhibits asbestos-induced cytotoxicity via a NF-κB-dependent pathway, a possible mechanism for asbestos-induced oncogenesis. Proc Natl Acad Sci 103(27):10397–10402

    Article  CAS  Google Scholar 

  • Yi M, Ban Y, Tan Y, Xiong W, Li G, Xiang B (2019) 6-Phosphofructo-2-kinase/fructose-2, 6-biphosphatase 3 and 4: a pair of valves for fine-tuning of glucose metabolism in human cancer. Mol Metab 20:1–13

    Article  Google Scholar 

  • Zhang G, Liu Z, Han Y, Wang X, Yang Z (2016) Overexpression of miR-509 increases apoptosis and inhibits invasion via suppression of tumor necrosis factor-α in triple-negative breast cancer Hs578T cells. Oncol Res 24(4):233–238

    Article  Google Scholar 

  • Zhao Y, Yang F, Li W, Xu C, Li L, Chen L et al (2017) miR-29a suppresses MCF-7 cell growth by downregulating tumor necrosis factor receptor 1. Tumour Biol 39(2):1010428317692264

    Article  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Student Research Committee, Department of Immunology, School of Medicine, Shahid Beheshti University of Medical Sciences, Tehran, Iran

    Safa Tahmasebi & Mina Alimohammadi

  2. Department of Immunology, School of Public Health, Tehran University of Medical Sciences, Tehran, Iran

    Sahar Khorasani

  3. Research Center for Immunodeficiencies, Children’s Medical Center, Tehran University of Medical Sciences, Tehran, Iran

    Nima Rezaei

  4. Department of Immunology, School of Medicine, Tehran University of Medical Sciences, Tehran, Iran

    Nima Rezaei

  5. Network of Immunity in Infection, Malignancy and Autoimmunity (NIIMA), Universal Scientific Education and Research Network (USERN), Stockholm, Sweden

    Nima Rezaei

Authors
  1. Safa Tahmasebi
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Mina Alimohammadi
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Sahar Khorasani
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Nima Rezaei
    View author publications

    You can also search for this author in PubMed Google Scholar

Editor information

Editors and Affiliations

  1. Division of Clinical Immunology, Karolinska University Hospital, Huddinge, Sweden

    Nima Rezaei

Rights and permissions

Reprints and permissions

Copyright information

© 2023 Springer Nature Switzerland AG

About this entry

Check for updates. Verify currency and authenticity via CrossMark

Cite this entry

Tahmasebi, S., Alimohammadi, M., Khorasani, S., Rezaei, N. (2023). Pro-tumorigenic and Anti-tumorigenic Roles of Pro-inflammatory Cytokines in Cancer. In: Rezaei, N. (eds) Handbook of Cancer and Immunology. Springer, Cham. https://doi.org/10.1007/978-3-030-80962-1_25-1

Download citation

  • DOI: https://doi.org/10.1007/978-3-030-80962-1_25-1

  • Received:

  • Accepted:

  • Published:

  • Publisher Name: Springer, Cham

  • Print ISBN: 978-3-030-80962-1

  • Online ISBN: 978-3-030-80962-1

  • eBook Packages: Springer Reference Biomedicine and Life SciencesReference Module Biomedical and Life Sciences

Publish with us

Policies and ethics

Search

Navigation